导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.39% | 523/1050 |
| 近一周 | 1.77% | 179/1104 |
| 近一月 | -7.54% | 759/1103 |
| 近一季 | -24.49% | 1020/1094 |
| 近半年 | 10.09% | 276/1074 |
| 近一年 | -5.05% | 655/1020 |
| 近两年 | 38.08% | 610/926 |
| 近三年 | 6.49% | 618/834 |
| 成立以来 | 123.46% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-15.23% 1053/1070 |
70.36% 141/1101 |
- - |
- - |
| 2025 | 15.26% 751/1065 |
-0.75% 846/1014 |
-5.50% 967/1038 |
39.16% 204/1050 |
-11.69% 931/1065 |
| 2024 | -4.35% 683/1011 |
-7.68% 681/960 |
0.72% 258/983 |
6.72% 830/991 |
-3.61% 580/1011 |
| 2023 | -15.49% 545/952 |
1.60% 533/880 |
4.09% 54/895 |
-17.76% 828/915 |
-2.84% 311/952 |
| 2022 | -27.05% 552/867 |
-16.60% 341/773 |
17.79% 56/806 |
-10.03% 241/845 |
-17.46% 839/867 |
| 2021 | 3.09% 326/740 |
-10.15% 494/580 |
26.26% 69/659 |
-11.85% 552/704 |
3.09% 301/740 |
| 2020 | 78.46% 97/554 |
-4.01% 262/419 |
38.17% 39/466 |
17.16% 97/517 |
14.84% 208/554 |
| 2019 | 37.21% 239/410 |
29.32% 411/1146 |
-2.77% 567/1228 |
6.08% 180/390 |
2.87% 375/410 |
| 2018 | -32.25% 246/349 |
- - |
1.24% 53/990 |
-12.30% 881/1000 |
-13.75% 806/1080 |
| 2017 | 61.95% 2/285 |
- - |
- - |
- - |
- - |
| 2016 | -1.49% 32/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 国泰互联网+股票 VS. 东吴新产业精选股票A(580008) |